Impact of Social Determinants of Health on Key Cardiometabolic Measures Amplified by New Research
Social determinants of health, including education and income level and race/ethnicity, are drivers of declining cardiometabolic health in the US, says investigator Meghan O'Hearn.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 18, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Risk of MCI Progression to Dementia Reduced with ARBs vs Other Hypertension Rx
A new study compared the differential effects of agents used to treat hypertension on the risk for dementia in patients with hypertension and mild cognitive impairment.
Refugee Immunization Requirements: A Pop Quiz
Refresh your memory on refugee immunization recommendations with a 3-question quiz based on a patient scenario.
Intermediate Cardiometabolic Risk: Study Author Explains this "Critical Inflection Point"
Americans sitting on the cusp of cardiometabolic disease, ie, with prediabetes, prehypertension, overweight but not obesity, need intervention, now.
Chronic Kidney Disease Present in 1 in 10 Adults: Study of 2.4 Million People in 11 Countries
Chronic kidney disease is underdiagnosed and undertreated across major Western countries, according to findings of the new CaReMe CKD study.
New MMR Vaccine Ready for Fall: How Will it Be Different?
The GSK MMR vaccine Priorix is the first new MMR shot to be available since the Merck immunization was approved in 1971. Similar? Different? Find out.
Management of Nonalcoholic Fatty Liver Disease in Adults: Guidelines for Primary Care Clinicians
An overview of recommendations from the American Association of Clinical Endocrinology for the management of NAFLD in adults.
Nonopioid Prescriptions for Pain Increased After 2016 CDC Guidelines Set Limits on Narcotics
A new study describes growth in prescribing of over-the-counter analgesics and other nonopioid treatments for chronic pain in the 3 years following the CDC guideline.
FDA Authorizes Novavax COVID-19 Vaccine for Adults, the First Protein-based Vaccine Available in US
The FDA issued an emergency use authorization for the Novavax COVID-19 Vaccine, Adjuvanted in individuals aged ≥18 years.
Diagnosis of Nonalcoholic Fatty Liver Disease in Adults: Guidelines for Primary Care
Get an overview of the recent AACE guidelines for diagnosing NAFLD in adults in primary care settings.
FDA Clears Heart Murmur Detection AI Software for Eko Smart Stethoscope
The cloud-based machine learning algorithm allows the stethoscope to identify and differentiate between innocent and structural murmurs that may signal valve disease.
11 Cardiology Highlights for Primary Care, January to June, 2022
These 11 studies of cardiovascular and metabolic disease prevention, assessment, and treatment were top trending topics on Patient Care in the first half of 2022.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 13, 2022
Chronic Sinusitis Flares Reduced by 66% in Pooled Analysis of Optinose ReOpen Program Data
For patients with chronic sinusitis, disease exacerbations often require use of antibiotics and steroids, in addition to medical office visits, all of which impact quality of life.
US Cardiometabolic Health at Alarming Suboptimal Levels, Says Lead Author of New NHANES Analysis
US prevalence of optimal cardiometabolic health has declined as poor levels have risen significantly over 2 decades. Investigator Meghan O'Hearn, MS, details the research.
Salt Added Frequently to Food May Increase Risk for Premature Mortality: Study
Adding salt regularly to food after cooking/preparation may increase risk of premature death by up to 28% and reduce life expectancy by an average of 2 years.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 12, 2022
Mayo Clinic Laboratories Begin Monkeypox Testing to Help Increase Access, Availability
Mayo Clinic Laboratory will use the CDC's orthopoxvirus test and expects to handle up to 10 000 tests per week.
Obeticholic Acid in NASH Significantly Improves Liver Fibrosis: Topline Phase 3 Study Findings
Results of the prespecified analysis from the REGENERATE trial confirm 2019 data demonstrating statistically significant improvement in fibrosis without worsening NASH.